Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

June 2024

Discover the Clinical Performance Results of Aiosyn Mitosis Breast at ECDP 2024

2024-06-04T08:45:10+00:00

Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, recently conducted a clinical performance study in collaboration with Radboud university medical center. This study evaluated the benefits of Aiosyn Mitosis Breast for mitotic figure detection in clinical settings. Following the presentation at the USCAP 113th Annual Meeting, these results will be showcased at the 20th European Congress on Digital Pathology.

Discover the Clinical Performance Results of Aiosyn Mitosis Breast at ECDP 20242024-06-04T08:45:10+00:00

Case Of The Month | June 2024 | Digital Cytology: Possible Cryptococcosis in a 10-year-old Domestic Shorthair Cat

2024-06-03T12:12:59+00:00

A 10-year-old domestic shorthair male cat presented with a recurrent nasal mass, which was initially excised surgically last year. The clinical pathology team at NationWide Laboratories performed a cytological examination of the mass using digital pathology images, revealing marked pyogranulomatous inflammation and suspicious yeast elements that were likely to be Cryptococcus. The presence of round to oval (11-12 um diameter) yeast structures with internal basophilic stippling and a thin clear external halo were observed both extracellularly and within macrophages. There were also frequent pseudohyphae observed in some areas. This looked consistent with a diagnosis of Cryptococcus infection. The digital images allowed for high-resolution visualisation of the fungal elements; however, further confirmation would require culture or PCR testing to definitively identify the species and determine the specific genotype involved.

Case Of The Month | June 2024 | Digital Cytology: Possible Cryptococcosis in a 10-year-old Domestic Shorthair Cat2024-06-03T12:12:59+00:00

May 2024

Lumea Named Overall State Winner for Science and Technology

2024-05-31T09:30:30+00:00

Lumea Inc., just after winning Utah's Best in State award for Medical Innovation, has now clinched the overall winning title for the Science and Technology trophy, Friday evening, triumphing over leading technology and biotechnology companies to secure one of the coveted ten overall awards out of 350+ subcategory winners.

Lumea Named Overall State Winner for Science and Technology2024-05-31T09:30:30+00:00

Paige Delivers the Power of Foundation Model Technology to Revolutionize Pharmaceutical & Life Science AI Development

2024-05-30T14:00:34+00:00

Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) applications, today announced the launch of a new service line based on Paige’s Foundation Models, including the world's largest multi-modal AI model in pathology and oncology. AI developers, organizations building computational pathology products, and life sciences companies will be able to license and use these Foundation Models to develop their own AI models for any research and development, clinical trials, experimental studies, or commercial needs while conforming to the highest set of privacy, security and clinical standards. The result could be a dramatic acceleration of innovation in precision oncology, improving the way cancer is diagnosed and treated around the world.  

Paige Delivers the Power of Foundation Model Technology to Revolutionize Pharmaceutical & Life Science AI Development2024-05-30T14:00:34+00:00

Patholytix 4.0, Becomes First Platform To Support Future-proof Study Archival Of Regulated Digital Safety Studies

2024-05-30T12:38:33+00:00

Deciphex, a pioneering leader in GLP-compliant digital pathology solutions, announces today that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies. Previously unavailable, this advancement strengthens digital pathology's use in GLP drug safety assessment.

Patholytix 4.0, Becomes First Platform To Support Future-proof Study Archival Of Regulated Digital Safety Studies2024-05-30T12:38:33+00:00

PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024

2024-05-30T10:38:05+00:00

The New Products Will Enable Scalable Immuno-Oncology Profiling and Assessment of IHC-Stained Tissue Respectively

PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 20242024-05-30T10:38:05+00:00

Indica Labs Announces AI-Powered HALO® Software Release for Digital Pathology Research in Life Sciences

2024-05-29T12:55:31+00:00

Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new version of its industry leading life sciences software. The 4.0 versions of HALO®, HALO AI, and HALO Link offer researchers and pathologists unparalleled ease of use and performance, with even more opportunities to leverage advanced AI-powered image analysis in an open digital pathology ecosystem.

Indica Labs Announces AI-Powered HALO® Software Release for Digital Pathology Research in Life Sciences2024-05-29T12:55:31+00:00

Source LDPath and Inbiomotion sign an exclusive agreement for MAF Test® in United Kingdom and Ireland

2024-05-28T14:00:31+00:00

Source BioScience, an industry-leading provider of genomic services and healthcare diagnostics, and Inbiomotion, a company commercializing its proprietary MAF Test® for identifying high risk early-stage breast cancer patients, have signed an exclusive agreement to start offering the MAF Test® as a service in United Kingdom and Ireland. The MAF Test® predicts the prognosis of breast cancer patients and helps oncologists to identify those patients who may be able to prevent recurrence and benefit from adjuvant treatment with bisphosphonates, which are commonly used to treat osteoporosis. The test also identifies those patients whose prognosis would worsen if treated with bisphosphonates.

Source LDPath and Inbiomotion sign an exclusive agreement for MAF Test® in United Kingdom and Ireland2024-05-28T14:00:31+00:00

Pathologist Perspective: Optimize Image Quality to Optimize Patient Care

2024-05-28T10:07:19+00:00

In this article, Rob Monroe details Sweden-based Inify Laboratories experience with development of a fully digital, AI-supported workflow to enhance timeliness, consistency and quality of cancer diagnoses.

Pathologist Perspective: Optimize Image Quality to Optimize Patient Care2024-05-28T10:07:19+00:00
Go to Top